GPAS

What GPAS does

The Ellison Institute of Technology Oxford (EIT), referenced as GPAS in the supplied dataset, is a privately held, philanthropy-backed research institute registered in England and Wales (company № 13773507) and headquartered at Winchester House, The Oxford Science Park, Oxford. It operates across four stated core endeavors: Health, Medical Science and Generative Biology; Food Security and Sustainable Agriculture; Climate Change and Managing Atmospheric CO2; and Artificial Intelligence and Robotics. These are delivered through a platform of specialized institutes and programs including the Generative Biology Institute, Plant Biology Institute, AI and Robotics Institute, Materials and Devices for Life Sciences, Pathogen Program (which houses the EIT Pathogena genomic analysis tool), Correlates of Immunity, Lithium Air Batteries, Africa Clinical Research Network, and an Economics Program. Core technology spans generative biology, autonomous AI-guided labs, foundation models, advanced statistical machine learning, and genomic analysis tooling.

EIT has no commercial revenue model. It distributes value through fully funded education (the Ellison Scholars Programme funds undergraduate and graduate study at the University of Oxford), collaborative research programs with Oxford, and open scientific publication. Customer-facing 'segments' are exceptional students globally and Oxford-affiliated researchers, not paying enterprise customers. Funding flows from philanthropy — primarily Larry Ellison — and a £130 million strategic alliance with the University of Oxford announced in December 2024, alongside a £10 billion science investment plan announced in October 2025. The institute is currently building a 300,000 sq ft Littlemore campus scheduled for 2027 completion, with a planned expansion to 2 million sq ft and 7,000 personnel capacity across The Oxford Science Park.

Recent strategic activity has been intensive: appointment of Professor Sir John Bell as President (February 2024) and Professor Santa Ono as Global President (August 2025), senior hires including Professor Jason Chin, Professor Hagan Bayley, Professor Gil McVean, and Professor Steve Kelly, the launch of EIT Pathogena (2024), and a lead investment in Wild Bioscience (October 2025). Operating geographies disclosed in the data are United Kingdom, with programs extending into Africa via the Africa Clinical Research Network.

Name

GPAS

Legal name

Ellison Institute of Technology, Oxford Limited

Website

https://gpas.global

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

The Ellison Institute of Technology Oxford is a philanthropy-backed, non-profit research institute conducting multidisciplinary science across health, generative biology, agriculture, climate, and AI/robotics, while fully funding exceptional students through the Ellison Scholars Programme at the University of Oxford.

Ownership category

akta.pro rank

Product category

Scientific Research Services

NAICS

Colleges, Universities, and Professional Schools (6113)

SIC

Services-Educational Services (8200)

akta.pro primary industry

STEM-Focused Research Universities (Engineering & Applied Sciences) (EDAHABAB)

akta.pro secondary industries

Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA), Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

• Scientific research institute
• Nonprofit research organization
• Ai foundation models
• Autonomous lab systems
• Fully funded scholarships

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Others

Distribution channels1 record

Marketing channels8 records

Core offering

GPAS is described as a non-profit scientific research institute that conducts research across multiple scientific domains including artificial intelligence, robotics, autonomous laboratory systems, and foundation models. It also offers fully funded education programs, including a scholarship programme in partnership with the University of Oxford, and is funded through philanthropy and strategic partnerships rather than commercial product sales.

Product overview

EIT Oxford operates as a multi-disciplinary research institute with a platform of specialized institutes, programs, and laboratories focused on four core endeavors: Health/Medical Science/Generative Biology, Food Security/Sustainable Agriculture, Climate Change/Managing Atmospheric CO2, and AI/Robotics. The organization encompasses the Generative Biology Institute, Plant Biology Institute, AI & Robotics Institute, Materials & Devices for Life Sciences, Pathogen Program (including EIT Pathogena), Correlates of Immunity, Lithium Air Batteries, Africa Clinical Research Network, and Economics Program. Education offerings include the Ellison Scholars Programme that fully funds studies at Oxford University. The institutes work in synergy to tackle complex interconnected challenges spanning technology, economics, and multiple scientific disciplines.

Differentiator

Problem solved

Functional benefit

Brands

• Generative Biology Institute: Building a global leading institute for engineering biology to unlock the power of biology for the benefit of humanity.
• Plant Biology Institute
• AI & Robotics Institute
• Pathogen Program
• Ellison Scholars
• EIT Pathogena
• Lithium Air Batteries
• Africa Clinical Research Network

Products and services

• Ellison Scholars Programme A fully funded scholarship and research training programme delivered in partnership with the University of Oxford, providing selected students and researchers with funded positions to pursue scientific research.
• Scientific Research Programs Multi-domain scientific research programs spanning artificial intelligence, robotics, autonomous laboratory systems, and foundation models, conducted in collaboration with university and strategic partners.

Quantifiable outcome

• Up to 7,000 people to be employed at expanded Oxford campus
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• The Oxford Science ParkcoreStrategic or Co-development Partner · 14 October 2025EIT announces plans for new expanded Oxford campus at The Oxford Science Park. Campus will span 2 million sq ft across western part of the park, designed to accommodate up to 7,000 people.
• Foster + PartnerscoreStrategic or Co-development Partner · 9 October 2025EIT and Foster + Partners collaborating to restore the iconic Oxford pub, The Eagle & Child - a historic venue known for the Inklings literary group. Lord Norman Foster serves as design lead for EIT's new campus.
• University of OxfordcoreStrategic or Co-development Partner · 3 December 2024Transformative strategic alliance with £130m investment to address humanity's greatest challenges. EIT and University of Oxford collaborate on research programs, with inaugural cohort of EIT-funded students welcomed to Oxford by Vice-Chancellor Professor Irene Tracey. Students collaborate with EIT supervisors on projects important to humanity.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Allen Institute: Philanthropically-funded (Paul Allen) research institute spanning brain science, cell science, and AI. Closely comparable in the funding/operating model (large-scale philanthropy, multi-disciplinary science, big-team research) and overlapping scope in AI for science.
• Wellcome Sanger Institute: UK genomics and pathogen research institute funded by the Wellcome Trust. Direct peer to EIT's Pathogen Program and EIT Pathogena, and similarly positioned as a UK-based, philanthropy-backed large-scale genomics operation.
• Salk Institute for Biological Studies: Independent, non-profit research organisation in San Diego conducting high-quality biological research. Comparable in operating model (private non-profit research institute with prestigious scientific leadership) and mission scope (fundamental biology with translational impact).
• Francis Crick Institute: UK-based biomedical discovery institute in London with ~1,500 scientists. Most direct geographic and functional peer — large-scale, interdisciplinary, well-funded life sciences research institute analogous to EIT's pathogen and generative biology programs.
• Broad Institute: MIT/Harvard-affiliated independent research institute pursuing large-scale genomic, chemical, and computational biology. Closest direct peer in mission (multi-disciplinary science for human benefit) and operational model (independent non-profit research org with significant philanthropic backing).
• Scripps Research Institute: Independent non-profit research organisation covering biomedical sciences and chemistry. Comparable in being a large private research institute pursuing fundamental science with translational applications, analogous to several EIT research programs.
• Chan Zuckerberg Biohub: Philanthropically-funded (Chan Zuckerberg Initiative) biomedical research institute pursuing large-scale biomedical science. Closely comparable operating model (private philanthropy, mission-driven multi-disciplinary institute, significant AI-biology convergence).

Broad incumbents

• Howard Hughes Medical Institute (HHMI): One of the largest US private funders of biomedical research and the HHMI Janelia Research Campus. Comparable as a very large-scale, philanthropy-driven biomedical research enterprise, though broader and longer-established than EIT.
• Max Planck Institutes: Network of 86 publicly-funded research institutes conducting fundamental research in natural sciences, life sciences, social sciences, and humanities. Comparable in the multi-disciplinary, institute-based research model with independent scientific leadership, though publicly funded rather than philanthropically funded.

Emerging players

• Karolinska Institutet: Sweden's single largest medical university with a strong research focus across biomedical and life sciences. Comparable to EIT in being a research-intensive organisation spanning health, biology, and translational medicine, and as an education-and-research integrated institution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/_gpas_
• Facebookfacebook.com/EITOxford
• LinkedInlinkedin.com/company/global-pathogen-analysis-service-ltd
• Instagraminstagram.com/eitoxford

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GPAS